Li  Ding, PhD

Li Ding, PhD

Primary Academic Title

Professor of Medicine, Division of Oncology, Section of Stem Cell Biology, Washington University School of Medicine

Research Interest

Identifying and characterizing somatic/germline genetic changes relevant to cancer initiation and progression as well as drug response by integrating various data types, including DNA, RNA and proteomics data. Developing algorithms to facilitate the translation of genomic findings to clinical practice.

Education

  • 1998: PhD, biochemistry, University of Utah, Salt Lake City

Training

  • 1998 - 2999: Postdoctoral fellow, biochemistry, Stanford University, Palo Alto, Calif.

Selected Research Publications

DeST-OT: Alignment of spatiotemporal transcriptomics data.
  • Halmos P, Liu X, Gold J, [...] Ding L, Raphael BJ
  • Cell Syst 2025
Germline predisposition in multiple myeloma.
  • Martins Rodrigues F, Jasielec J, Perpich M, [...] Ding L
  • iScience 2025
RSK1 is an exploitable dependency in myeloproliferative neoplasms and secondary acute myeloid leukemia.
  • Kong T, Laranjeira ABA, Letson CT, [...] Ding L, [...] Oh ST
  • Nat Commun 2025
Breaking frontiers with multidisciplinary cancer research.
  • Caldas C, Chen X, Ding L, Kather JN , Scaltriti M
  • Nat Cancer 2025
SenNet recommendations for detecting senescent cells in different tissues.
  • Suryadevara V, Hudgins AD, Rajesh A, [...] Ding L, [...] Neretti N
  • Nat Rev Mol Cell Biol 2024
A proteogenomic analysis of cervical cancer reveals therapeutic and biological insights.
  • Yu J, Gui X, Zou Y, [...] Ding L, [...] Gao D
  • Nat Commun 2024
Defining precancer: a grand challenge for the cancer community.
  • Faupel-Badger J, Kohaar I, Bahl M, [...] Ding L, [...] Srivastava S
  • Nat Rev Cancer 2024
Multi-scale signaling and tumor evolution in high-grade gliomas.
  • Liu J, Cao S, Imbach KJ, [...] Ding L
  • Cancer Cell 2024
Senescence Defines a Distinct Subset of Myofibroblasts That Orchestrates Immunosuppression in Pancreatic Cancer.
  • Belle JI, Sen D, Baer JM, [...] Ding L, [...] DeNardo DG
  • Cancer Discov 2024
Comprehensive proteogenomic characterization of rare kidney tumors.
  • Li GX, Chen L, Hsiao Y, [...] Ding L, [...] Nesvizhskii AI
  • Cell Rep Med 2024

View All Publications